We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.9B
AUM Growth
+$1.02B
Cap. Flow
+$744M
Cap. Flow %
6.82%
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
565
Reduced
595
Closed
1,134

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Healthcare 9.21%
3 Consumer Discretionary 8.28%
4 Industrials 6.28%
5 Materials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VECO icon
2201
Veeco
VECO
$3.15B
$275K ﹤0.01%
11,474
-60,451
-84% -$1.38M
WABC icon
2202
Westamerica Bancorp
WABC
$1.37B
$275K ﹤0.01%
4,749
-2,068
-30% -$129K
DBC icon
2203
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$274K ﹤0.01%
+14,251
New +$260K
IOSP icon
2204
Innospec
IOSP
$2.25B
$273K ﹤0.01%
3,023
+90
+3% +$8.92K
DNAB
2205
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$273K ﹤0.01%
+26,994
New +$273K
AVEO
2206
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$273K ﹤0.01%
+41,428
New +$286K
MSAC
2207
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$272K ﹤0.01%
+28,193
New +$276K
FCAC
2208
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$272K ﹤0.01%
+29,322
New +$292K
SRG
2209
Seritage Growth Properties
SRG
$136M
$271K ﹤0.01%
+14,767
New +$262K
BOH icon
2210
Bank of Hawaii
BOH
$3.12B
$270K ﹤0.01%
3,217
-33,201
-91% -$2.97M
SEB icon
2211
Seaboard Corp
SEB
$4.1B
$270K ﹤0.01%
70
-150
-68% -$562K
BBLN
2212
DELISTED
Babylon Holdings Limited
BBLN
$270K ﹤0.01%
+1,094
New +$269K
AGRX
2213
DELISTED
Agile Therapeutics
AGRX
$270K ﹤0.01%
+102
New +$336K
ATRA icon
2214
Atara Biotherapeutics
ATRA
$74.3M
$269K ﹤0.01%
+693
New +$247K
AVNS
2215
DELISTED
Avanos Medical
AVNS
$269K ﹤0.01%
7,417
-716
-9% -$29.6K
FSS icon
2216
Federal Signal
FSS
$7.8B
$269K ﹤0.01%
6,699
+195
+3% +$8.01K
BURL icon
2217
Burlington
BURL
$23.4B
$268K ﹤0.01%
+834
New +$265K
GENI.WS
2218
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
$268K ﹤0.01%
+33,781
New +$282K
FCCY
2219
DELISTED
1st Constitution Bancorp
FCCY
$268K ﹤0.01%
+13,000
New +$255K
BILL icon
2220
BILL Holdings
BILL
$4.68B
$267K ﹤0.01%
1,460
-53,973
-97% -$8.46M
VXUS icon
2221
Vanguard Total International Stock ETF
VXUS
$158B
$267K ﹤0.01%
+4,073
New +$267K
GSIT icon
2222
GSI Technology
GSIT
$254M
$266K ﹤0.01%
+47,385
New +$292K
ICHR icon
2223
Ichor Holdings
ICHR
$2.45B
$266K ﹤0.01%
+4,947
New +$272K
TELA icon
2224
TELA Bio
TELA
$38.5M
$266K ﹤0.01%
+16,536
New +$227K
CORR
2225
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$266K ﹤0.01%
+40,272
New +$258K

Similar funds

HRT Financial's Q2 2021 Portfolio in Review

As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HRT Financial deployed $744M of net new capital in Q2 2021, opening 1,275 new positions and adding to 565 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.

  • HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
  • HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
  • HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
  • HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
  • HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
  • HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
  • HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.